Oocyte Retrieval Products Market Scope
Egg retrieval is also known as egg retrieval. Egg retrieval is a procedure in which viable eggs are removed from the ovaries for the in Vitro fertilization process. Egg retrieval is an important part of the Vitro fertilization process, so the growth in IVF procedures is expected to drive demand for egg retrieval products. The high success rate and continuous technological progress are also some of the factors that have further supported the demand for these products. Factors such as high infertility rates and government initiatives to offer better health insurance coverage for IVF procedures are expected to further increase demand for egg retrieval products. To capitalize on the growth opportunities in the egg collection products market, product manufacturers are focusing on introducing improved products that provide doctors with better precision during the procedure, which in turn reduces patient pain throughout the procedure and provides effective treatment.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | CooperSurgical Inc. (United States), Vitrolife (Sweden), Gynotech BV (Netherlands), Kitazato Corporation (Japan), Cook Medical (United States), BIOPSYBELL S.R.L. (Italy), weLLgo Medical Products GmbH (Germany) and Shanghai Horizon Medical Co. Ltd. (China) |
CAGR | % |
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Oocyte Retrieval Products market throughout the predicted period.
CooperSurgical Inc. (United States), Vitrolife (Sweden), Gynotech BV (Netherlands), Kitazato Corporation (Japan), Cook Medical (United States), BIOPSYBELL S.R.L. (Italy), weLLgo Medical Products GmbH (Germany) and Shanghai Horizon Medical Co. Ltd. (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Rocket Medical plc (United Kingdom) and Planer Limited (United Kingdom).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Oocyte Retrieval Products market by Type , by Application (In-VitroFertility Centers (IVF), Hospitals, Gynecology Clinics and Research Institutes) and Region with country level break-up.
On the basis of geography, the market of Oocyte Retrieval Products has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In April 2018, Kitazato Corporation had entered into a strategic partnership with SPECTRUN, one of the distributors in Brazil, to supply various assisted technology products such as egg collection needles and related devices.
In January 2021, Shanghai Horizon Medical Co., Ltd. Horizon Medical had received approval for its egg aspiration needle from the Thai Food and Drug Administration (TFDA). This makes it the first product to receive international approval.
Influencing Trend:
Availability of Wider Treatment Options and Shorter Waiting Times and The Trend in Delayed Pregnancies, Late Puberty, Certain Hereditary Factors
Market Growth Drivers:
A Rise in Infertility Rates, The High Success Rate of the IVF Procedure, The Growth in the Number of IVF Clinics in Developing Regions and Lower Cost of IVF Treatments
Challenges:
Lack of Awareness
Restraints:
High Cost of the Oocyte Retrieval Procedure and The Complications Associated With the Egg Retrieval Procedure Such As Infection and Pain in the Pelvis and the Ovaries
Opportunities:
The Growing Fertility Tourism and Rising Technological Advancements in Healthcare Industry
Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Oocyte Retrieval Products, Government Regulatory and Research Organizations and End-Use Industries